Description
Altrenogest is a progestogen used in veterinary settings. This progesterone agonist is most commonly used to suppress or control the estrous cycle of female animals.
Product Unit Size | Cost | Quantity | Stock |
---|
Altrenogest is a progestogen used in veterinary settings. This progesterone agonist is most commonly used to suppress or control the estrous cycle of female animals.
Cas No. | 850-52-2 |
---|---|
Purity | ≥98% |
Formula | C21H26O2 |
Formula Wt. | 310.44 |
Chemical Name | 17-α-Allyl-17-β-hydroxyoestra-4,9,11-trien-3-one |
IUPAC Name | (8S,13S,14S,17R)-17-hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15, 16-octahydrocyclopenta[a]phenanthren-3-one |
Synonym | (17beta)-17-Allyl-17-hydroxyestra-4,9,11-trien-3-one, Altrenogestrel, Allyltrenbolone, Regumate |
Appearance | Slight yellow powder |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Horsley BR, Estienne MJ, Harper AF, et al. Effect of P.G. 600 on the timing of ovulation in gilts treated with altrenogest. J Anim Sci. 2005 Jul;83(7):1690-5. PMID: 15956478.
dos Santos JM, Wentz I, Bortolozzo FP, et al. Early-weaned sows: altrenogest therapy, estrus, ovulation, and reproductive performance. Anim Reprod Sci. 2004 Sep;84(3-4):407-13. PMID: 15302382.
Webel SK, Squires EL. Control of the oestrous cycle in mares with altrenogest. J Reprod Fertil Suppl. 1982;32:193-8. PMID: 6962854.
EGFR inhibitor.
Peptide, used to deliver conjugated drugs to ce...
Thrombin substrate used to measure thrombin act...
Building block
AT-II antagonist, PPARγ/δ modulator.
Endogenous cardiomodulatory peptide; NPR-B agon...
Expectorant.
β1-adrenergic antagonist.
ASK1 inhibitor.
Chloroethylnitrosourea, DNA alkylator and cross...
Serine protease substrate/inhibitor.
Dicarboxylic acid found in Arabidopsis; PPARγ ...
Core structure of melatonin; potential PPARγ a...
Fluoroquinolone; topoisomerase IV and bacterial...
NSAID; COX-1/2 and PDE inhibitor.
Hydroxypyridone, metal ion chelator; mTOR inhib...
Antimicrobial peptide found in amphibians.
COVID-19 research
PARP inhibitor; potential Pim1 inhibitor.
Cannabinoid receptor 2 selective agonist.